WASHINGTON – United States regulators are moving ahead with a crackdown on scores of antibody tests for the coronavirus that have not yet been shown to work.
The Food and Drug Administration on Thursday published a list of more than two dozen test makers that have failed to file applications to remain on the market or already pulled their products.
The agency said in a statement that it expects the tests “will not be marketed or distributed.” It was unclear if any of the companies would face additional penalties.
Most companies faced a deadline earlier this week to file paperwork demonstrating their tests’ performance. Regulators required it after previously allowing tests to launch with minimal oversight, which critics said had created a “Wild West” of unregulated testing. (AP)
